The University of Texas MD Anderson Cancer, Department of Diagnostic Radiology, Division of Diagnostic Imaging, 1515 Holcombe Blvd., Unit 1350, Houston, TX 77030.
The University of Texas MD Anderson Cancer, Department of Diagnostic Radiology, Division of Diagnostic Imaging, 1515 Holcombe Blvd., Unit 1350, Houston, TX 77030.
Acad Radiol. 2020 Mar;27(3):389-394. doi: 10.1016/j.acra.2019.05.012. Epub 2019 Jul 13.
We investigated if imaging or pathology features could determine when imaging follow-up is appropriate after diagnosis of radial scar on digital breast tomosynthesis (DBT)-guided core needle biopsy (CNB).
We conducted a retrospective review of all patients diagnosed with radial scars on DBT-guided CNB at our institution between November 2014 and December 2016. Cases were excluded if DCIS or invasive malignancy was present in the same core specimens. Patient age; needle size; number of cores; visibility on full-field digital mammography versus DBT; lesion size; presence of architectural distortion, mass, or calcifications; imaging stability; presence or absence of atypia; length of imaging follow-up, and excisional pathology were collected.
Of 45 eligible biopsies, 6 cases had radial scars with associated atypia and 39 cases had no associated atypia. Twenty-four patients underwent surgical excision, including all patients with atypia on CNB. One case (4%) was upstaged to DCIS on surgical excision after CNB revealed a radial scar with associated ADH. There was also a case without atypia on CNB, but excisional pathology revealed associated ADH. In cases with radial scars and associated atypia on CNB, the upstage rate was 17%. In cases without atypia on CNB that underwent surgical excision, the upstage rate was 0%. Imaging follow-up was available in 13 patients who did not undergo surgical excision, with stability in all 13 with a median follow-up of 18 months.
Annual imaging follow-up appears reasonable in selected patients with radial scars but no atypia on DBT-guided CNB.
我们旨在探讨在数字乳腺断层摄影引导的核心针活检(CNB)诊断为放射状瘢痕后,影像学随访的适宜时机是否可以通过影像学或病理学特征来确定。
我们对 2014 年 11 月至 2016 年 12 月在我院接受数字乳腺断层摄影引导的 CNB 诊断为放射状瘢痕的所有患者进行了回顾性研究。如果在同一核心标本中存在 DCIS 或浸润性恶性肿瘤,则排除病例。收集患者年龄、针的大小、核心的数量、全视野数字化乳腺摄影与数字乳腺断层摄影的可视性、病变大小、是否存在结构扭曲、肿块或钙化、影像学稳定性、是否存在非典型性、影像学随访的长度以及切除病理等资料。
在 45 例符合条件的活检中,有 6 例为伴有非典型性的放射状瘢痕,39 例为无非典型性的放射状瘢痕。24 例患者接受了手术切除,包括所有 CNB 有非典型性的患者。1 例(4%)在 CNB 显示为伴有 ADH 的放射状瘢痕后,在手术切除时升级为 DCIS。还有 1 例 CNB 无非典型性,但切除病理显示有 ADH。在 CNB 有放射状瘢痕伴非典型性的病例中,升级率为 17%。在 CNB 无非典型性且接受手术切除的病例中,升级率为 0%。13 例未接受手术切除的患者有影像学随访资料,所有患者均稳定,中位随访时间为 18 个月。
在数字乳腺断层摄影引导的 CNB 无放射状瘢痕但有非典型性的特定患者中,每年进行影像学随访是合理的。